Got $2,000? These 2 Tech Stocks Can Make You a Fortune

Which two tech companies should you hold in your portfolio for massive gains?

| More on:

Tech companies are my favourite to invest in. The biggest reason for this would be the fact that my circle of competence happens to fall within this sector. Luckily for me, this is one of the most exciting spaces to invest in, and certainly one of the most lucrative. Of all the possible tech companies to invest in, in Canada, which two should investors be watching right now?

An acquisition giant

The first company that can make you a fortune is actually a fairly large company now. Constellation Software (TSX:CSU) made its name by strategically acquiring strong tech companies. Over time, Constellation built up a very large portfolio of subsidiaries that the company has helped grow into great companies.

Although it’s true that larger companies tend to grow slower than small companies, Constellation is “only” a $32.18 billion market cap. This makes it a large cap company, but still relatively smaller than some of the biggest companies in Canada. The reason I am so bullish on this large cap company is because of its management. President and Chairman of the Board Mark Leonard founded the company in 1995 and is still heavily involved today.

To put Constellation’s amazing growth into perspective, consider this. When the company had its IPO in 2006, shares were valued at $18.30 at close, giving Constellation a market cap of $387.77 million. As of this writing, shares have grown 8,200% over the next 14 years and are now valued at $1,518.58.

Mark Leonard previously wrote annual letters to shareholders. These letters gave updates on the company’s business and acquisitions. In 2017, Leonard announced the he would stop doing so and “only write to shareholders when [he thinks he has] something new and important to communicate.”

This strategy also prevents “copycat companies” from imitating Constellation’s strategy and maintains its competitive advantage in the market. Because of these reasons, Constellation Software should be on every Canadian investor’s watchlist.

A necessary company moving forward

From a large cap company to a small cap, the second company that is sure to make investors a fortune is Docebo (TSX:DCBO). This is a company that I have featured on The Motley Fool quite a bit, so investors should already be familiar with it. For those that are not, the company provides an e-learning platform for enterprises.

As I have stated in previous articles, the company has two very strong tailwinds working in its favour: the COVID-19 pandemic and the fact that many industries around the world are becoming more digital. I will only focus on the latter in this article.

If you look at any industry right now, you will notice that there are companies out there that are helping optimize businesses.  A big part in optimization requires that businesses become more digital. For instance, there are companies that help provide supply chain software and services, automate the due diligence and filing generation process, and those that provide an array of services within the e-commerce and merchant industries.

Docebo is the leader in online enterprise training. It currently has many clients from all around the world. Some of which are large cap companies from the United States and Canada. Since its IPO late last year, Docebo stock has already gained more than 260%. I am confident this company has much more growth to look forward to in the future.

Foolish takeaway

Massive gains in the tech sector are not unheard of. In fact, you do not even need to choose very risky companies. A large company like Constellation Software and a smaller company working in an essential industry like Docebo are examples of companies that can be very rewarding to investors.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Jed Lloren owns shares of Docebo Inc. The Motley Fool owns shares of and recommends Constellation Software.

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »